These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 9255344)

  • 21. Bortezomib-induced skin eruption.
    Sanchez-Politta S; Favet L; Kerl K; Dietrich PY; Piguet V
    Dermatology; 2008; 216(2):156-8. PubMed ID: 18216478
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assay of the synthetic estrogen fosfestrol in pharmaceutical formulations using capillary electrophoresis.
    G Themelis D; Trellopoulos AV; Tzanavaras PD; Karlberg B
    J Pharm Biomed Anal; 2005 Sep; 39(3-4):559-63. PubMed ID: 15953702
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Direct approximation of plasma concentration time curves of 3-diethylstilbestrol monoglucuronide following oral and intravenous administration of fosfestrol].
    Rothley D; Oelschläger H
    Pharmazie; 1986 Dec; 41(12):862-4. PubMed ID: 3575391
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Geographic distribution of lapatinib-induced skin rash: sparing of abdominal skin persists in the transverse rectus abdominis myocutaneous flap.
    Lin NU; Kasparian E; Morganstern DE; Beard C
    J Clin Oncol; 2009 Dec; 27(34):e218-9. PubMed ID: 19786662
    [No Abstract]   [Full Text] [Related]  

  • 25. [Histologic variants of drug-induced toxicoderma].
    Thomine E
    Ann Pathol; 1992; 12(4-5):268-75. PubMed ID: 1466683
    [No Abstract]   [Full Text] [Related]  

  • 26. Sorafenib: atypical cutaneous side effects.
    Richetta AG; Maiani E; Carboni V; Carlomagno V; Cimillo M; Mattozzi C; Calvieri S
    Eur J Dermatol; 2007; 17(6):549-50. PubMed ID: 17951148
    [No Abstract]   [Full Text] [Related]  

  • 27. Morbilliform drug reaction with histologic features of pustular dermatosis associated with bryostatin-1.
    Krejci-Manwaring JM; Bogle MA; Diwan HA; Duvic MA
    J Drugs Dermatol; 2003 Oct; 2(5):557-61. PubMed ID: 14558406
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cutaneous reactions to imatinib mesylate treated by topical steroid.
    Ujiie H; Shimizu T; Shimizu H
    Am J Hematol; 2005 Mar; 78(3):246. PubMed ID: 15726597
    [No Abstract]   [Full Text] [Related]  

  • 29. Fosfestrol: Honvan, ST 52, Honvol, Fosfostilben. A review of new pharmacokinetic and clinical data. Workshop at the 3rd International Congress on Hormones and Cancer. Hamburg, September 6-11, 1987.
    Urol Int; 1988; 43 Suppl 1():1-58. PubMed ID: 3195000
    [No Abstract]   [Full Text] [Related]  

  • 30. Skin lesions induced by bortezomib.
    Pour L; Hajek R; Zdenek A; Krejci M; Krivanova A; Vorlicek J
    Haematologica; 2005 Dec; 90(12 Suppl):ECR44. PubMed ID: 16464759
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Onset of psoriasis with psoriatic arthropathy during rituximab treatment of non-Hodgkin lymphoma.
    Mielke F; Schneider-Obermeyer J; Dörner T
    Ann Rheum Dis; 2008 Jul; 67(7):1056-7. PubMed ID: 18556453
    [No Abstract]   [Full Text] [Related]  

  • 32. [Dermatologic reactions to amifostine].
    Moreno Alvarez PJ; Madurga Sanz M
    Farm Hosp; 2003; 27(3):200-1. PubMed ID: 12835824
    [No Abstract]   [Full Text] [Related]  

  • 33. Heliotrope-like eruption mimicking dermatomyositis in a patient treated with imatinib mesylate for chronic myeloid leukemia.
    Kuwano Y; Asahina A; Watanabe R; Fujimoto M; Ihn H; Tamaki K
    Int J Dermatol; 2006 Oct; 45(10):1249-51. PubMed ID: 17040457
    [No Abstract]   [Full Text] [Related]  

  • 34. 2-chlorodeoxyadenosine (cladribine) induced allergic cutaneous reactions with eosinophilia in a patient with B-cell chronic lymphocytic leukemia.
    Robak T; Sysa-Jedrzejowska A; Robak E; Dabkowski J; Blasinska-Morawiec M
    J Med; 1997; 28(3-4):199-209. PubMed ID: 9355024
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cutaneous vasculitis developed in a patient with breast cancer undergoing aromatase inhibitor treatment.
    Shoda H; Inokuma S; Yajima N; Tanaka Y; Setoguchi K
    Ann Rheum Dis; 2005 Apr; 64(4):651-2. PubMed ID: 15769928
    [No Abstract]   [Full Text] [Related]  

  • 36. Serious cutaneous reactions to amifostine.
    Prescrire Int; 2003 Dec; 12(68):225. PubMed ID: 14986696
    [No Abstract]   [Full Text] [Related]  

  • 37. Cutaneous drug eruptions induced by sorafenib: a case series.
    Maddox JS; Kung EF; Petronic-Rosic V; Sethi A
    J Drugs Dermatol; 2008 Sep; 7(9):891-3. PubMed ID: 19112807
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The treatment of local lesions caused by the administration of chemotherapeutic preparations].
    Chekharina EA
    Med Sestra; 1991 Feb; 50(2):21-2. PubMed ID: 1828524
    [No Abstract]   [Full Text] [Related]  

  • 39. Chronic penile ulceration in a 72-year-old man.
    Geraminejad PA; Walling HW; Swick BL; Sontheimer RD
    Arch Dermatol; 2004 Jul; 140(7):877-82. PubMed ID: 15262703
    [No Abstract]   [Full Text] [Related]  

  • 40. Skin toxicity of anti-cancer therapy.
    Ulrich J; Hartmann JT; Dörr W; Ugurel S
    J Dtsch Dermatol Ges; 2008 Nov; 6(11):959-77. PubMed ID: 18992037
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.